• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 213/60 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Patent holdings for IPC class C07D 213/60

Total number of patents in this class: 106

10-year publication summary

5
3
8
5
2
10
2
10
4
4
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Principal owners for this class

Owner
All patents
This class
BASF SE
21303
4
Syngenta Participations AG
1527
4
Bayer Pharma AG
1014
4
Bayer Cropscience AG
1846
3
BeiGene, Ltd.
256
3
The Brigham and Women's Hospital, Inc.
2282
3
H. Lundbeck A/S
1231
3
Merck Sharp & Dohme Corp.
2183
2
Battelle Memorial Institute
2603
2
Alcon, Inc.
5848
2
Beijing Yiling Bioengineering Co., Ltd.
3
2
Kyoto University
2898
2
Medshine Discovery Inc.
587
2
NATCO Pharma Limited
204
2
Nihon Medi-physics Co., Ltd.
177
2
sanofi-aventis
302
2
Qingdao Kingagroot Chemical Compound Co., Ltd.
222
2
Merck Sharp & Dohme LLC
3735
2
Soter Biopharma Pte. Ltd.
8
2
Bristol-myers Squibb Company
4729
1
Other owners 57